Khuri F - Search Results

1

Farnesyltransferase inhibitor SCH66336 induces rapid phosphorylation of eukaryotic translation elongation factor 2 in head and neck squamous cell carcinoma cells.

Ren H, Tai SK, Khuri F, Chu Z, Mao L. Ren H, et al. Among authors: khuri f. Cancer Res. 2005 Jul 1;65(13):5841-7. doi: 10.1158/0008-5472.CAN-04-3141. Cancer Res. 2005. PMID: 15994961

2

Molecular epidemiology and retinoid chemoprevention of head and neck cancer.

Khuri FR, Lippman SM, Spitz MR, Lotan R, Hong WK. Khuri FR, et al. J Natl Cancer Inst. 1997 Feb 5;89(3):199-211. doi: 10.1093/jnci/89.3.199. J Natl Cancer Inst. 1997. PMID: 9017000 Review.

3

Clonal genetic alterations in the lungs of current and former smokers.

Mao L, Lee JS, Kurie JM, Fan YH, Lippman SM, Lee JJ, Ro JY, Broxson A, Yu R, Morice RC, Kemp BL, Khuri FR, Walsh GL, Hittelman WN, Hong WK. Mao L, et al. Among authors: khuri fr. J Natl Cancer Inst. 1997 Jun 18;89(12):857-62. doi: 10.1093/jnci/89.12.857. J Natl Cancer Inst. 1997. PMID: 9196251

4

Recent advances in paclitaxel-containing chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck.

Shin DM, Glisson BS, Khuri FR, Ginsberg L, Lawhorn K, Hong WK, Lippman SM. Shin DM, et al. Among authors: khuri fr. Semin Oncol. 1997 Dec;24(6 Suppl 19):S19-33-S19-37. Semin Oncol. 1997. PMID: 9427263 Clinical Trial.

5

Phase II trial of paclitaxel, ifosfamide, and cisplatin in patients with recurrent head and neck squamous cell carcinoma.

Shin DM, Glisson BS, Khuri FR, Ginsberg L, Papadimitrakopoulou V, Lee JJ, Lawhorn K, Gillenwater AM, Ang KK, Clayman GL, Callender DL, Hong WK, Lippman SM. Shin DM, et al. Among authors: khuri fr. J Clin Oncol. 1998 Apr;16(4):1325-30. doi: 10.1200/JCO.1998.16.4.1325. J Clin Oncol. 1998. PMID: 9552033 Clinical Trial.

6

Role of paclitaxel, ifosfamide, and cisplatin in patients with recurrent or metastatic squamous cell carcinoma of the head and neck.

Shin DM, Glisson BS, Khuri FR, Hong WK, Lippman SM. Shin DM, et al. Among authors: khuri fr. Semin Oncol. 1998 Apr;25(2 Suppl 4):40-4; discussion 45-8. Semin Oncol. 1998. PMID: 9578061 Clinical Trial.

7

Loss of Fhit is frequent in stage I non-small cell lung cancer and in the lungs of chronic smokers.

Tseng JE, Kemp BL, Khuri FR, Kurie JM, Lee JS, Zhou X, Liu D, Hong WK, Mao L. Tseng JE, et al. Among authors: khuri fr. Cancer Res. 1999 Oct 1;59(19):4798-803. Cancer Res. 1999. PMID: 10519387

8

Prognostic implication of microsatellite alteration profiles in early-stage non-small cell lung cancer.

Zhou X, Kemp BL, Khuri FR, Liu D, Lee JJ, Wu W, Hong WK, Mao L. Zhou X, et al. Among authors: khuri fr. Clin Cancer Res. 2000 Feb;6(2):559-65. Clin Cancer Res. 2000. PMID: 10690539

9

Differential expression of E-cadherin and type IV collagenase genes predicts outcome in patients with stage I non-small cell lung carcinoma.

Herbst RS, Yano S, Kuniyasu H, Khuri FR, Bucana CD, Guo F, Liu D, Kemp B, Lee JJ, Hong WK, Fidler IJ. Herbst RS, et al. Among authors: khuri fr. Clin Cancer Res. 2000 Mar;6(3):790-7. Clin Cancer Res. 2000. PMID: 10741698

10

Adenocarcinoma of the lung in young patients: the M. D. Anderson experience.

Liu NS, Spitz MR, Kemp BL, Cooksley C, Fossella FV, Lee JS, Hong WK, Khuri FR. Liu NS, et al. Among authors: khuri fr. Cancer. 2000 Apr 15;88(8):1837-41. doi: 10.1002/(sici)1097-0142(20000415)88:8<1837::aid-cncr12>3.0.co;2-e. Cancer. 2000. PMID: 10760760

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

513 results

Search Page

Filters